This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Flu Test Sales Boost Meridian 3Q Profit 16 Percent

CINCINNATI (AP) ¿ Meridian Bioscience Inc. said Thursday its profit rose 16 percent in its fiscal fourth quarter due to strong sales of its rapid flu test, which is marketed as a potential detector of swine flu.

Meridian said its profit grew to $8.9 million, or 22 cents per share, from $7.7 million, or 19 cents per share, a year earlier. Revenue rose 16 percent to $42.5 million from $36.5 million.

According to a Thomson Reuters survey, analysts were expecting 21 cents per share and $38.7 million in revenue.

The company reported strong sales of respiratory products, including its TRU FLU kit, which is approved to detect seasonal flu. It also said sales of its test for the respiratory syncytial virus were solid. RSV is the most common cause of lower respiratory tract illnesses in infants and young children.

In mid-September, the Food and Drug Administration allowed Meridian to update the packaging of TRU FLU to indicate it is sensitive to two swine flu strains. TRU FLU's ability to detect the strains has not been proved.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
VIVO $19.86 -4.00%
AAPL $94.85 -3.00%
FB $117.00 7.40%
GOOG $691.20 -2.10%
TSLA $247.54 -1.60%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,073.69 -21.46 -1.02%
NASDAQ 4,801.7040 -61.4370 -1.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs